Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/8839
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-07-07T17:41:12Z-
dc.date.available2022-07-07T17:41:12Z-
dc.date.issued2015-03-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/8839-
dc.subjectFenômenos Farmacológicos e Toxicológicospt_BR
dc.subjectPharmacological and Toxicological Phenomenapt_BR
dc.subjectFenómenos Farmacológicos y Toxicológicospt_BR
dc.subjectUso de Medicamentospt_BR
dc.subjectDrug Utilizationpt_BR
dc.subjectUtilización de Medicamentospt_BR
dc.titleInteração medicamentosa: entenda os riscos de se medicar sem orientaçãopt_BR
dc.title.alternativeInforme INCA 334pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 334

Files in This Item:
File Description SizeFormat 
Informe INCA 334-11.pdf51.37 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.